Immediate Impact

3 by Nobel laureates 14 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
2 intermediate papers

Works of Benjamin N. Greener being referenced

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
2023
RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations
2017

Author Peers

Author Last Decade Papers Cites
Benjamin N. Greener 168 130 92 106 8 307
Sheikh Abdul Rahman 151 133 67 136 10 371
Stefano Berrè 144 101 157 48 8 346
Jori Symons 138 145 100 77 14 290
J C Galphin 122 186 120 120 8 363
Anouk Van Nuffel 106 222 63 95 8 313
Kaitlin M. Smith 112 83 109 75 8 262
Ann Dauphin 98 223 62 110 7 322
Hikaru Yamanaka 93 186 147 121 9 361
Sébastien Desfarges 79 162 54 154 7 286
Raul Gomila 182 250 94 71 8 369

All Works

Loading papers...

Rankless by CCL
2026